3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma
539
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Lymphoma, Non-Hodgkin
435
Lymphoma, Follicular
403
Leukemia, Lymphocytic, Chronic, B-Cell
388
Lymphoma, Large B-Cell, Diffuse
385
Lymphoma, B-Cell
246
Lymphoma, Mantle-Cell
222
Hodgkin Disease
207
Recurrence
204
Leukemia, Myeloid, Acute
197
Leukemia
191
Multiple Myeloma
184
Burkitt Lymphoma
181
Lymphoma, B-Cell, Marginal Zone
170
Neoplasms
151
Myelodysplastic Syndromes
132
Hematologic Neoplasms
115
Waldenstrom Macroglobulinemia
103
Lymphoma, T-Cell, Peripheral
85
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
81
Lymphoma, T-Cell
81
Lymphoma, T-Cell, Cutaneous
66
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
62
Mycosis Fungoides
57
Leukemia, Biphenotypic, Acute
54
Breast Neoplasms
54
Myeloproliferative Disorders
50
Leukemia, B-Cell
50
Lymphoproliferative Disorders
47
Interventions
gamma-Globulins
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bacterial Infections
×
Lymphoid
×
1 year
×
Clear all
NCT05645107
2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3
Recruiting
386 enrolled